MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA

被引:36
|
作者
Chen, Hanwen [1 ]
Gao, Shuming [1 ]
Cheng, Cai [1 ]
机构
[1] Cangzhou Cent Hosp, Dept Orthoped 1, Cangzhou 061000, Hebei, Peoples R China
关键词
MiR-323a-3p; Osteosarcoma; LDHA; Glycolysis; CELL-PROLIFERATION; AEROBIC GLYCOLYSIS; MIRNA EXPRESSION; GASTRIC-CANCER; INVASION; INHIBITION; METABOLISM; MIGRATION;
D O I
10.1007/s13577-018-0215-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Accumulating evidence has demonstrated that there is critical involvement of miRNAs in the initiation and progression of cancers. Here, we showed that miR-323a-3p was significantly down-regulated in osteosarcoma (OS) tissues and cell lines. Overexpression of miR-323a-3p decreased the cell viability, colon formation and induced the apoptosis of OS cells. Using bioinformatics analysis, lactate dehydrogenase A (LDHA) was predicted as one of the down-steam targets of miR-323a-3p. Highly expressed miR-323a-3p significantly decreased both the mRNA and protein levels of LDHA. Inverse correlation between the expression of LDHA and miR-323a-3p was observed in OS tissues. Consistent with the function of LDHA in glycolysis of cancer cells, overexpression of miR-323a-3p attenuated the lactate production of OS cells. These results demonstrated that miR-323a-3p suppressed the growth of OS cells via targeting LDHA and inhibited the glycolysis of OS. This study provides insight into the molecular mechanism of miR-323a-3p in regulating OS.
引用
收藏
页码:300 / 309
页数:10
相关论文
共 50 条
  • [31] Long Non-coding RNA EBLN3P Regulates UHMK1 Expression by Sponging miR-323a-3p and Promotes Colorectal Cancer Progression
    Xu, Xiang-hao
    Song, Wen
    Li, Jun-hua
    Huang, Ze-qi
    Liu, Ya-fang
    Bao, Qiang
    Shen, Zhi-wen
    FRONTIERS IN MEDICINE, 2021, 8
  • [32] Long noncoding RNA HAGLR sponges miR-338-3p to promote 5-Fu resistance in gastric cancer through targeting the LDHA-glycolysis pathway
    Hu, Jing
    Huang, Lujie
    Ding, Qi
    Lv, Jiaming
    Chen, Zhe
    CELL BIOLOGY INTERNATIONAL, 2022, 46 (02) : 173 - 184
  • [33] Follicular fluid-derived extracellular vesicles miR-34a-5p regulates granulosa cell glycolysis in polycystic ovary syndrome by targeting LDHA
    Cui, Xueying
    Lei, Xiaocan
    Huang, Tao
    Mao, Xueyan
    Shen, Zhiwei
    Yang, Xiuli
    Peng, Wanting
    Yu, Jingjing
    Zhang, Shun
    Huo, Peng
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [34] miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL
    Tian, Rui
    Xie, Xianbiao
    Han, Ju
    Luo, Canqiao
    Yong, Bicheng
    Peng, Huizhi
    Shen, Jingnan
    Peng, Tingsheng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (06): : 738 - 750
  • [35] miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN
    He, Ming
    Shen, Peng
    Qiu, Chuang
    Wang, Jiashi
    AGING-US, 2019, 11 (15): : 5744 - 5756
  • [36] LncRNA-HOTAIRM1 promotes aerobic glycolysis and proliferation in osteosarcoma via the miR-664b-3p/Rheb/mTOR pathway
    Yu, Xuecheng
    Duan, Weihao
    Wu, Furen
    Yang, Daibin
    Wang, Xin
    Wu, Jingbin
    Zhou, Dong
    Shen, Yifei
    CANCER SCIENCE, 2023, 114 (09) : 3537 - 3552
  • [37] MiR-141-3p overexpression suppresses the malignancy of osteosarcoma by targeting FUS to LDHB
    Wang, Lei
    BIOSCIENCE REPORTS, 2020, 40
  • [38] Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma
    Dai, Hongchun
    Yi, Guangming
    Jiang, Dong
    Min, Yanmei
    Li, Zongwei
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01)
  • [39] Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma
    Hongchun Dai
    Guangming Yi
    Dong Jiang
    Yanmei Min
    Zongwei Li
    Journal of Orthopaedic Surgery and Research, 19
  • [40] miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16
    Shi, Jianhui
    An, Gang
    Guan, Ying
    Wei, Tianli
    Peng, Zhibin
    Liang, Min
    Wang, Yansong
    CANCER CELL INTERNATIONAL, 2019, 19 (1)